• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性碘131治疗的分化型甲状腺癌患者中的嗜酸性粒细胞阳离子蛋白

Eosinophil Cationic Protein in Patients with Differentiated Thyroid Cancer Treated with Radioactive Iodine 131.

作者信息

Zivancevic-Simonovic Snezana, Mihaljevic Olgica, Kostic Irena, Ilic Nevenka, Mihajlovic Dusan, Vasiljevic Dragan, Mijatovic-Teodorovic Ljiljana, Miletic-Drakulic Svetlana, Colic Miodrag

机构信息

Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia

Department of Pathophysiology, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.

出版信息

Ann Clin Lab Sci. 2017 Sep;47(5):541-545.

PMID:29066479
Abstract

Published data indicate the involvement of eosinophil granulocytes and eosinophil cationic protein (ECP) in tumor defense. The aim of this study was to analyze serum ECP concentrations in patients with differentiated thyroid cancer (DTC) before, 3 days and 7 days after radioactive iodine (131-I) therapy. Association of ECP concentrations with histological type of tumor, stage of disease and/or levels of selected T-helper 2 (Th2) cytokines was examined. The study population included 17 DTC patients and 10 control subjects. ECP was measured by fluoroimmunoassay (FIA). Th2 (cytokines interleukin 4 (IL-4), interleukin 5 (IL-5), and interleukin 13 (IL-13)) were determined by enzyme-linked immunosorbent assays (ELISA). We found that ECP values in DTC patients before radioactive iodine therapy were approximately two-fold higher than in the controls, but the difference was statistically significant only if the patients with DTC and associated Hashimoto thyroiditis (HT) were included. There was no correlation between the serum concentrations of IL-5 and ECP. Radioactive iodine therapy led to a decrease in serum ECP level which did not follow the decline in serum protein levels. Additional studies are needed to determine the significance of these findings.

摘要

已发表的数据表明嗜酸性粒细胞和嗜酸性粒细胞阳离子蛋白(ECP)参与肿瘤防御。本研究的目的是分析分化型甲状腺癌(DTC)患者在放射性碘(131-I)治疗前、治疗后3天和7天的血清ECP浓度。研究了ECP浓度与肿瘤组织学类型、疾病分期和/或选定的辅助性T细胞2(Th2)细胞因子水平之间的关联。研究人群包括17例DTC患者和10例对照受试者。通过荧光免疫测定法(FIA)测量ECP。通过酶联免疫吸附测定法(ELISA)测定Th2(细胞因子白细胞介素4(IL-4)、白细胞介素5(IL-5)和白细胞介素13(IL-13))。我们发现,放射性碘治疗前DTC患者的ECP值比对照组高约两倍,但只有纳入患有DTC和相关桥本甲状腺炎(HT)的患者时,差异才有统计学意义。IL-5血清浓度与ECP之间无相关性。放射性碘治疗导致血清ECP水平下降,且这一下降与血清蛋白水平的下降不一致。需要进一步研究以确定这些发现的意义。

相似文献

1
Eosinophil Cationic Protein in Patients with Differentiated Thyroid Cancer Treated with Radioactive Iodine 131.放射性碘131治疗的分化型甲状腺癌患者中的嗜酸性粒细胞阳离子蛋白
Ann Clin Lab Sci. 2017 Sep;47(5):541-545.
2
Cytokine production in peripheral blood cells of patients with differentiated thyroid cancer: elevated Th2/Th9 cytokine production before and reduced Th2 cytokine production after radioactive iodine therapy.分化型甲状腺癌患者外周血细胞细胞因子的产生:放射性碘治疗前 Th2/Th9 细胞因子产生增加,治疗后 Th2 细胞因子产生减少。
Cancer Immunol Immunother. 2015 Jan;64(1):75-82. doi: 10.1007/s00262-014-1619-7. Epub 2014 Oct 9.
3
Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.甲状腺广泛乳头状癌经外照射放疗、手术和术后放射性碘治疗。
Eur Arch Otorhinolaryngol. 2009 Nov;266(11):1837-9. doi: 10.1007/s00405-009-0948-1. Epub 2009 Mar 18.
4
Impact of Patient Age and Histological Type on Radioactive Iodine Avidity of Recurrent Lesions of Differentiated Thyroid Carcinoma.患者年龄和组织学类型对分化型甲状腺癌复发病灶放射性碘摄取的影响。
Clin Nucl Med. 2018 Jul;43(7):482-485. doi: 10.1097/RLU.0000000000002078.
5
[Treatment of differentiated carcinoma of the thyroid gland].[甲状腺分化型癌的治疗]
Nihon Naika Gakkai Zasshi. 1997 Jul 10;86(7):1184-9.
6
Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.甲状腺全切术联合放射性碘消融及促甲状腺激素抑制治疗的乳头状甲状腺癌患者中肿瘤大小和灶性与复发/持续存在的相关性
Updates Surg. 2018 Mar;70(1):121-127. doi: 10.1007/s13304-017-0465-5. Epub 2017 May 26.
7
Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.放射性碘给药时机对分化型甲状腺癌患者的预后无影响。
Thyroid. 2016 Nov;26(11):1623-1629. doi: 10.1089/thy.2016.0038. Epub 2016 Sep 22.
8
Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.使用循证指南可减少低风险分化型甲状腺癌患者的放射性碘治疗。
Thyroid. 2015 Apr;25(4):377-85. doi: 10.1089/thy.2014.0298. Epub 2015 Feb 6.
9
Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.甲状腺切除术后放射性碘残留摄取:并非如此彻底的癌症手术。
Ann Surg Oncol. 2014 Apr;21(4):1379-83. doi: 10.1245/s10434-013-3450-3. Epub 2013 Dec 31.
10
Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.通过逆转录聚合酶链反应检测血液甲状腺球蛋白和促甲状腺激素受体mRNA用于分化型甲状腺癌患者的随访
Rev Esp Med Nucl. 2010 May-Jun;29(3):109-13. doi: 10.1016/j.remn.2009.12.010.

引用本文的文献

1
A Systematic Review of the Preventive and Therapeutic Effects of Naringin Against Human Malignancies.柚皮苷对人类恶性肿瘤预防和治疗作用的系统评价
Front Pharmacol. 2021 Mar 29;12:639840. doi: 10.3389/fphar.2021.639840. eCollection 2021.